ChristopherGravesGoetzMD

PubMed

• Apathy in Parkinson disease: Why we should care.
  Joseph H. Friedman, Christopher G. Goetz> ;Neurology. 2020 Oct 1
• Measuring Medication Adherence in Parkinson's Disease: A Systematic Review of Contributing Components in Rating Scales.
  Michelle Hyczy de Siqueira Tosin, Glenn T. Stebbins, Christopher G. Goetz, Rosimere Ferreira Santana, Marco Antonio Araujo Leite, Beatriz Guitton Renaud Baptista de Ol...> ;Movement Disorders Clinical Practice. 2020 Jun 15
• Scales to assess impulsive and compulsive behaviors in Parkinson's disease: Critique and recommendations.
  Evans, A. H.,Okai, D.,Weintraub, D.,Lim, S. Y.,O'Sullivan, S. S.,Voon, V.,Krack, P.,Sampaio, C.,Post, B.,Leentjens, AFG.,Martinez-Martin, P.,Stebbins, G. T.,Goetz, C. ...> ;Mov. Disord.. 2019 May 29
• The Parkinson's disease e-diary: Developing a clinical and research tool for the digital age.
  Joaquin A. Vizcarra, Álvaro Sánchez-Ferro, Walter Maetzler, Luca Marsili, Lucia Zavala, Anthony E. Lang, Pablo Martinez-Martin, Tiago A. Mestre, Ralf Reilmann, Jeffrey...> ;Movement Disorders. 2019 May 1
• Developing Skills That Serve Our Journal, Your Colleagues as Potential Authors, and You.
  Goetz, C. G.> ;Mov Disord Clin Pract. 2019 Apr 06
• Clinimetric Properties of the Fragile X-associated Tremor Ataxia Syndrome Rating Scale.
  Hall, D. A.,Stebbins, G. T.,Jacquemont, S.,Berry-Kravis, E.,Goetz, C. G.,Hagerman, R.,Zhang, L.,Leehey, M. A.> ;Mov Disord Clin Pract. 2019 Mar 07
• Parkinson's disease: Is it a consequence of human brain evolution?
  Diederich, N. J.,James Surmeier, D.,Uchihara, T.,Grillner, S.,Goetz, C. G.> ;Mov. Disord.. 2019 Feb 14
• Telemedicine vs Office Visits in a Movement Disorders Clinic: Comparative Satisfaction of Physicians and Patients
  Ryan E. Hanson, Marisa Truesdell, Glenn T. Stebbins, Allison L. Weathers, Christopher G. Goetz> ;Movement Disorders Clinical Practice. 2018 Dec 13
• Missing Data in the Unified Dysksinesia Rating Scale (UDysRS).
  Luo, S.,Ren, X.,Han, W.,Goetz, C. G.,Stebbins, G. T.> ;Mov Disord Clin Pract. 2018 Dec 06
• Clinical Rating Scales for Urinary Symptoms in Parkinson Disease: Critique and Recommendations.
  Pavy-Le Traon, A.,Cotterill, N.,Amarenco, G.,Duerr, S.,Kaufmann, H.,Lahrmann, H.,Tison, F.,Wenning, G. K.,Goetz, C. G.,Poewe, W.,Sampaio, C.,Schrag, A.,Rascol, O.,Mart...> ;Mov Disord Clin Pract. 2018 Dec 06
• Rating Scales for Motor Symptoms and Signs in Huntington's Disease: Critique and Recommendations.
  Mestre, T. A.,Forjaz, M. J.,Mahlknecht, P.,Cardoso, F.,Ferreira, J. J.,Reilmann, R.,Sampaio, C.,Goetz, C. G.,Cubo, E.,Martinez-Martin, P.,Stebbins, G. T.> ;Mov Disord Clin Pract. 2018 Oct 27
• Movement disorder society criteria for clinically established early Parkinson's disease.
  Berg, D.,Adler, C. H.,Bloem, B. R.,Chan, P.,Gasser, T.,Goetz, C. G.,Halliday, G.,Lang, A. E.,Lewis, S.,Li, Y.,Liepelt-Scarfone, I.,Litvan, I.,Marek, K.,Maetzler, C.,Mi...> ;Mov. Disord.. 2018 Aug 27
• Validation of the MDS clinical diagnostic criteria for Parkinson's disease.
  Postuma, R. B.,Poewe, W.,Litvan, I.,Lewis, S.,Lang, A. E.,Halliday, G.,Goetz, C. G.,Chan, P.,Slow, E.,Seppi, K.,Schaffer, E.,Rios-Romenets, S.,Mi, T.,Maetzler, C.,Li, ...> ;Mov. Disord.. 2018 Aug 27
• What influences placebo and nocebo responses in Parkinson's disease?
  Witek, N.,Stebbins, G. T.,Goetz, C. G.> ;Mov. Disord.. 2018 Aug 23
• Rating Scales and Performance‐based Measures for Assessment of Functional Ability in Huntington's Disease: Critique and Recommendations
  Tiago A. Mestre, Monica Busse, Aileen M. Davis, Lori Quinn, Filipe B. Rodrigues, Jean-Marc Burgunder, Noelle E. Carlozzi, Francis O. Walker, Aileen K Ho, Cristina Samp...> ;Movement Disorders Clinical Practice. 2018 Jul 1
• Reply: Hoehn and Yahr stage 3 and Postural stability item in the Movement Disorder Society-Unified Parkinson's Disease Rating Scale.
  Skorvanek, M.,Martinez-Martin, P.,Stebbins, G. T.,Goetz, C. G.> ;Mov. Disord.. 2018 Aug 29
• Validation study of the hoehn and yahr scale included in the MDS-UPDRS
  Pablo Martinez-Martin, Matej Skorvanek, Jose Manuel Rojo-Abuin, Zuzana Gregova, Glenn T. Stebbins, Christopher G. Goetz> ;Movement Disorders. 2018 Apr 1
• Reply: MoCA for cognitive screening in Parkinson's disease: Beware of floor effect.
  Skorvanek, M.,Goldman, J. G.,Jahanshahi, M.,Marras, C.,Rektorova, I.,Schmand, B.,van Duijn, E.,Goetz, C. G.,Weintraub, D.,Stebbins, G. T.,Martinez-Martin, P.> ;Mov. Disord.. 2018 Feb 21
• Turkish Standardization of Movement Disorders Society Unified Parkinson's Disease Rating Scale and Unified Dyskinesia Rating Scale.
  Muhittin Cenk Akbostanci, Ece Bayram, Volkan Yilmaz, Sefer Rzayev, Serhat Ozkan, Ayse Bora Tokcaer, Esen Saka, Fatma Nazli Durmaz Çelik, Banu Özen Barut, Zeynep Tufekc...> ;Movement Disorders Clinical Practice. 2018 Jan 1
• Closing the celebration of 200 years of Parkinson's Essay on the Shaking Palsy: Where do we go in the next 200 years?
  Christopher G. Goetz> ;Movement Disorders. 2017 Dec 1
• Rating scales for cognition in Huntington's disease: Critique and recommendations.
  Mestre, T. A.,Bachoud-Lévi, A. C.,Marinus, J.,Stout, J. C.,Paulsen, J. S.,Como, P.,Duff, K.,Sampaio, C.,Goetz, C. G.,Cubo, E.,Stebbins, G. T.,Martinez-Martin, P.> ;Mov. Disord.. 2017 Dec 27
• Global scales for cognitive screening in Parkinson's disease: Critique and recommendations.
  Skorvanek, M.,Goldman, J. G.,Jahanshahi, M.,Marras, C.,Rektorova, I.,Schmand, B.,van Duijn, E.,Goetz, C. G.,Weintraub, D.,Stebbins, G. T.,Martinez-Martin, P.> ;Mov. Disord.. 2017 Nov 24
• Past, present, and future of Parkinson's disease: A special essay on the 200th Anniversary of the Shaking Palsy.
  J. A. Obeso, Maria Stamelou, Christopher G. Goetz, W. Poewe, Anthony E. Lang, Daniel Weintraub, David J. Burn, Glenda M. Halliday, Erwan Bezard, Serge Przedborski, Sté...> ;Movement Disorders. 2017 Sep 1
• Differential Item Functioning in the Unified Dyskinesia Rating Scale (UDysRS)
  Christopher Goetz, MD> ;Movement Disorders. 2017 Jun 02
• Dramatic Science or Scientific Drama?
  Christopher Goetz, MD> ;Brain.
• Join now to see all